Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
11:03
National Bureau of Statistics: Promote a higher level of dynamic balance between production and demand, driving market prices to stabilize and rise.
11:02
The Hang Seng TECH Index's decline has widened to 1%, and the Hang Seng Index is currently down 0.50%.
Hang Seng TECH Index-1.39%
11:02
The overnight SHIBOR is reported at 1.4210%, an increase of 1.7 basis points; the 7-day SHIBOR is reported at 1.7620%, an increase of 0.4 basis points; the 3-month SHIBOR is reported at 1.7250%, a decrease of 1.0 basis point.